AbbVie to buy Stemcentrx in $5.8 billion deal By: MarketWatch April 28, 2016 at 10:01 AM EDT AbbVie agreed to buy Stemcentrx, gaining lung cancer treatment. Read More >> Related Stocks: AbbVie Macy's